CL2004001343A1 - Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. - Google Patents
Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana.Info
- Publication number
- CL2004001343A1 CL2004001343A1 CL200401343A CL2004001343A CL2004001343A1 CL 2004001343 A1 CL2004001343 A1 CL 2004001343A1 CL 200401343 A CL200401343 A CL 200401343A CL 2004001343 A CL2004001343 A CL 2004001343A CL 2004001343 A1 CL2004001343 A1 CL 2004001343A1
- Authority
- CL
- Chile
- Prior art keywords
- biciclo
- carboxilico
- lactama
- heptano
- trioxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/861—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrocarbon radical or a substituted hydrocarbon radical, directly attached in position 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47645603P | 2003-06-05 | 2003-06-05 | |
| US49842203P | 2003-08-27 | 2003-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004001343A1 true CL2004001343A1 (es) | 2005-04-22 |
Family
ID=33514083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200401343A CL2004001343A1 (es) | 2003-06-05 | 2004-06-01 | Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050004093A1 (es) |
| EP (1) | EP1636240A1 (es) |
| JP (1) | JP2006526612A (es) |
| AR (1) | AR044482A1 (es) |
| BR (1) | BRPI0410936A (es) |
| CA (1) | CA2528065A1 (es) |
| CL (1) | CL2004001343A1 (es) |
| MX (1) | MXPA05012895A (es) |
| NL (1) | NL1026340C2 (es) |
| PA (1) | PA8604001A1 (es) |
| PE (1) | PE20050629A1 (es) |
| TW (1) | TW200504010A (es) |
| UY (1) | UY28340A1 (es) |
| WO (1) | WO2004108733A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8579701A1 (es) * | 2002-08-23 | 2005-05-24 | Pfizer Prod Inc | Profarmaco inhibidor de beta-lactamasa |
| WO2004087331A1 (de) | 2002-10-14 | 2004-10-14 | H. Börger & Co. GmbH | Verfahren und vorrichtung zum fördern von pulverförmigem material |
| GB201407506D0 (en) | 2014-04-29 | 2014-06-11 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| US9737505B2 (en) | 2014-04-29 | 2017-08-22 | Glaxosmithkline Intellectual Property Development Limited | Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE34011B1 (en) * | 1969-03-13 | 1975-01-08 | Leo Pharm Prod Ltd | New penicillin esters |
| IE34019B1 (en) * | 1969-03-18 | 1975-01-08 | Leo Pharm Prod Ltd | New semi-synthetic penicillin esters |
| US3957764A (en) * | 1969-11-11 | 1976-05-18 | Lovens Kemiske Fabrik Produktionsaktieselskab | 6-aminopenicillanic acid derivatives |
| US3862181A (en) * | 1970-10-28 | 1975-01-21 | Squibb & Sons Inc | Process for preparing cephalosporins |
| US4397783A (en) * | 1979-03-05 | 1983-08-09 | Pfizer Inc. | Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners |
| US4287181A (en) * | 1979-10-22 | 1981-09-01 | Pfizer Inc. | Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors |
| US4432970A (en) * | 1979-11-23 | 1984-02-21 | Pfizer Inc. | 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors |
| GB2076812A (en) * | 1980-05-22 | 1981-12-09 | Ciba Geigy Ag | Penam-dioxide compounds, processes for their manufacture, and their use |
| AU559689B2 (en) * | 1981-09-22 | 1987-03-19 | Kureha Kagaku Kogyo K.K. | Penicillin derivative |
| US4406887A (en) * | 1981-10-13 | 1983-09-27 | Bristol-Myers Company | Method for treating resistant bacteria including anaerobes |
| US4377590A (en) * | 1982-05-10 | 1983-03-22 | Pfizer Inc. | Derivatives of ampicillin and amoxicillin with beta-lactamase inhibitors |
| US4428935A (en) * | 1982-05-24 | 1984-01-31 | Pfizer Inc. | Penicillanic acid dioxide prodrug |
| US4826833A (en) * | 1984-01-30 | 1989-05-02 | Pfizer Inc. | 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof |
| US4521533A (en) * | 1984-07-12 | 1985-06-04 | Pfizer Inc. | Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics |
| US4762921A (en) * | 1985-04-18 | 1988-08-09 | Pfizer Inc. | 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives |
| US5200403A (en) * | 1987-07-10 | 1993-04-06 | Farmitalia Carlo Erba S.R.L. | Inhibition of βlactamase with 6 β-(substituted methyl)-penicillanic acid derivatives |
| JPH03206038A (ja) * | 1990-01-08 | 1991-09-09 | Yoshitomi Pharmaceut Ind Ltd | 抗菌剤 |
| GB9001405D0 (en) * | 1990-01-22 | 1990-03-21 | Leo Pharm Prod Ltd | New intermediates,their production and use |
| EP0544906B1 (en) * | 1990-08-20 | 1999-11-10 | Suntory Limited | Antibacterial penem esters derivatives |
| GB9208492D0 (en) * | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| US6156745A (en) * | 1997-12-29 | 2000-12-05 | Research Corporation Technologies, Inc. | 2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors |
| US6160112A (en) * | 1999-03-03 | 2000-12-12 | Alex-Gyogyszer Kutatasi, Fejlesztesi es Tanacsado Korlatot Felelossegu Tarsagag | Procedure for the preparation of dioxopenicillanic acid derivatives |
| PA8579701A1 (es) * | 2002-08-23 | 2005-05-24 | Pfizer Prod Inc | Profarmaco inhibidor de beta-lactamasa |
-
2004
- 2004-05-24 JP JP2006508430A patent/JP2006526612A/ja active Pending
- 2004-05-24 BR BRPI0410936-8A patent/BRPI0410936A/pt not_active IP Right Cessation
- 2004-05-24 MX MXPA05012895A patent/MXPA05012895A/es not_active Application Discontinuation
- 2004-05-24 WO PCT/IB2004/001824 patent/WO2004108733A1/en not_active Application Discontinuation
- 2004-05-24 CA CA002528065A patent/CA2528065A1/en not_active Abandoned
- 2004-05-24 EP EP04734576A patent/EP1636240A1/en not_active Withdrawn
- 2004-06-01 CL CL200401343A patent/CL2004001343A1/es unknown
- 2004-06-02 UY UY28340A patent/UY28340A1/es not_active Application Discontinuation
- 2004-06-02 PE PE2004000557A patent/PE20050629A1/es not_active Application Discontinuation
- 2004-06-02 PA PA20048604001A patent/PA8604001A1/es unknown
- 2004-06-03 AR ARP040101928A patent/AR044482A1/es unknown
- 2004-06-04 TW TW093116149A patent/TW200504010A/zh unknown
- 2004-06-04 NL NL1026340A patent/NL1026340C2/nl not_active IP Right Cessation
- 2004-06-07 US US10/862,200 patent/US20050004093A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| UY28340A1 (es) | 2005-01-31 |
| NL1026340C2 (nl) | 2005-09-14 |
| PA8604001A1 (es) | 2004-12-16 |
| NL1026340A1 (nl) | 2004-12-07 |
| AR044482A1 (es) | 2005-09-14 |
| TW200504010A (en) | 2005-02-01 |
| WO2004108733A1 (en) | 2004-12-16 |
| EP1636240A1 (en) | 2006-03-22 |
| BRPI0410936A (pt) | 2006-06-27 |
| PE20050629A1 (es) | 2005-08-25 |
| MXPA05012895A (es) | 2006-02-22 |
| CA2528065A1 (en) | 2004-12-16 |
| JP2006526612A (ja) | 2006-11-24 |
| US20050004093A1 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052787D0 (no) | N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| WO2008126034A3 (en) | Oxazolidinone antibiotics | |
| BRPI0415288A (pt) | composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto | |
| AU2003268156A1 (en) | Novel pyrazolopyridine derivatves as pharmaceutical agents | |
| DK1649760T3 (da) | Sammensætning, som indeholder equol-producerende mælkesyrebakterie | |
| NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| WO2006120563A3 (en) | Antibacterial agents | |
| CL2007000918A1 (es) | Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica. | |
| ATE353894T1 (de) | Acyloxymethylcarbamat-prodrugs von oxazolidinonen | |
| WO2006108681A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria | |
| SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| NO20044548L (no) | Fremgangsmate for fremstilling av 6-alkaliden-penemderivater | |
| AU2003210258A1 (en) | Piperidine ouracil used as a medicament for treating bacterial infections | |
| ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
| NO20074167L (no) | Peptidiske forbindelser | |
| CL2004001343A1 (es) | Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. | |
| NO20080314L (no) | Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika | |
| WO2005041853A3 (en) | Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. | |
| ITBO20030050A1 (it) | Macchina per il trattamento di prodotti farmaceutici. | |
| DK1439840T3 (da) | Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf | |
| CL2007003518A1 (es) | Compuestos derivados de quinolina sustituida; proceso de preparacion; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una infeccion bacteriana. | |
| AU2003232666A1 (en) | Ampoule for antiseptic solution or injection | |
| ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
| WO2009077485A3 (en) | 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents |